13^th International Conference on Surgical Pathology & Practice March 27-28, 2017 Madrid, Spain

Klaus Weber was born in East Germany and became a veterinarian and a biologist, and is currently studying in parallel to his professional activities geology at the University of Bern. He was working in laboratories in East German and also, for several years in human pathology. With over 25 years of professional experience in human and animal pathology. Weber was from 1991-2011 head of pathology at RCC/Harlan Laboratories. Klaus Weber has experience in all laboratory species including fish and invertebrates. His area of work covers short and long term as well as oncogenicity studies with specialties in implant pathology, neuropathology, inhalation pathology, bone marrow differentiation and various other topics. His work resulted in numerous presentations and publications. He founded in 2004 AnaPath GmbH in Switzerland, a holding that covered ten independent pathologists. After termination of his contract with Harlan Laboratories, he founded by the end of 2012 a new company in Switzerland called AnaPath Services GmbH, functionally active from spring 2013 onwards that covers with 32 technicians all subjects on the field of toxicological pathology including necropsy at client sites and histotechnique including all specialties.

His research mainly focuses on neuropathology, bone marrow differentiation and oncogeniity.

Shahla Masood is currently a Professor and Chair of the Department of Pathology at University of Florida College of Medicine, Jacksonville and Chief of Pathology and Laboratory Medicine at Shands Jacksonville. She is also the Director of the Pathology Residency Training Program, as well as Cytopathology and Breast Pathology Fellowship Training Program. In addition, she is the Medical Director of Shands Jacksonville Breast Health Center. An internationally recognized expert in breast cancer diagnosis and prognosis, she has fostered the concept of an integrated multidisciplinary approach in breast cancer care, research and education. She has recently been appointed to chair a committee of the National Accreditation Program for Breast Centers (NAPBC) with a new initiative to explore the possibility of expansion of this program to an international level.

Her research interests include Cancer diagnosis, Breast Cancer and Breast Cancer Prognosis.

Jürgen Karl-Josef Hescheler (born 2 May 1959) is a German physician and stem cell researcher. He is director to the Institute for Neurophysiology and a university professor at the University of Cologne. Prof. Hescheler is one of the most eminent and the most productive stem cell researchers worldwide, averaging more than 1000 citations of his publications per year. Hescheler has been working with embryonic stem cells since the late 80’s. He became the first researcher to accomplish an electrophysiological characterisation of stem cells and was also among the first scientists in Germany obtaining permission to do research on human embryonic stem cells.

His research interests include stem cell research and research on human embryonic stem cells.

Suzana Manxhuka-Kërliu, with over 26 years of clinical and academic experience focuses on medical education, publications and innovative learning techniques. As an anatomic pathologist, she is trained in Zagreb, Croatia and as a surgical pathologist at Memorial Sloan-Kettering Cancer Center-MSKCC/NY, USA and European School of Pathology, in Turin, Italy. Furthermore, she participated as an Erasmus Mundus/Basileus/Visiting Professor at the University of Rome La Sapienza as well as part of the Compostela Group of Universities in the Basque Country University in San Sebastian, Spain. As a Vice-Rector of the University of Prishtina, she provided the strategy, mission and vision for the internationalization of the University. Developed National Research Strategic plan for the development of the Scientific Research in the Country as well as the Framework for the Assessment of Scientific Research Institutions as an Executive Committee member of the National Research Council (NRC). Participated as Kosovo representative for the Medical Education in Europe-MEDINE. She served as a Director of Preclinical Institutes, Head of the PhD studies as well as the Head of the Residency program in Anatomic & Forensic Pathology. Also, she contributes as an Editorial Panel Member in the International Journal of Pediatric Research (IJPR), EC-Cancer Journal and Lectito Journal of Medicine; reviewer in many European Journals and has written more than 100 publications, as well as original and translated books. Currently, she is a Dean of the Faculty of Medicine/University of Prishtina, Professor of Anatomic Pathology; President of the National Board for Cancer Control, President of Kosova Task Force for Cancer Control-KTCC; Vice-President of Mediterranean Task Force for Cancer Control-MTCC & Vice-President of Italian-Kosovo League of Oncology (IKLO), member of the General Assembly of UICC as well as a member of European Society of Pathology-ESP and of many other professional associations.

Her research mainly focuses on medical education, publications and innovative learning techniques.

Shigeru Hirabayashi, an orthopaedic surgeon, graduated from The University of Tokyo in1978. Since 2007, he is a Professor of Department of Orthopaedic Surgery of Teikyo University Hospital and a Dean of Faculty of Medical Sciences of Teikyo University of Science. His special field is compressed myelopathy due to degenerative spinal diseases such as cervical myelopathy (spondylotic, OPLL: ossification of the posterior longitudinal ligament), and thoracic myelopathy (OPLL, OLF: ossification of the ligamentum flavum).

His research interests include Orthopaedic Surgery and Spinal diseases.

Santiago Ramon y Cajal is trained as Pathologist at the Jimenez Díaz Foundation in Madrid, and in the University of Yale. From 1990 to 2003 he worked as Pathologist at the Clinica Puerta de Hierro in Madrid, and since 2003 he has served as Chairman of the Pathology Department at Vall d Hebron Hospital and as Professor of Medicine at the Autonomous University of Barcelona. In 2013, he was a Visiting Profesor at McGill University and in 2014 he completed a master program in the IESE Business School. University of Navarra. PDD, for Leadership Development and Business Administration. He have published over 220 articles in peer-reviewed journals and presented over 500 communications at national and international meetings. He has been the P.I of more than 30 research projects based on the identification of new oncogenic factors and new approaches in gene and molecular therapy.

His research mainly focuses on cellular stress in malignant cells and cancer.